Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Lazarowski

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Frontiers in Bioscience (Landmark Edition)|June 5, 2014
ABC-transporters as stem-cell markers in brain dysplasia/tumor epilepsiesLilliana Czornyj, Alberto Lazarowski
Drug Metabolism and Drug Interactions|May 12, 2011
Potential role of multidrug resistant proteins in refractory epilepsy and antiepileptic drugs interactionsAlberto Lazarowski, Liliana Czornyj
Epilepsy & Behavior : E&B|November 11, 2019
The role of P-glycoprotein (P-gp) and inwardly rectifying potassium (Kir) channels in sudden unexpected death in epilepsy (SUDEP)Jerónimo Auzmendi, Enes Akyuz, Alberto Lazarowski
Epilepsia Open|September 20, 2021
Transporter hypothesis in pharmacoresistant epilepsies. Is it at the central or peripheral level?Liliana Czornyj, Jerónimo Auzmendi, Alberto Lazarowski
Current Pharmaceutical Design|March 28, 2013
Erythropoietin: a neuroprotective agent in cerebral hypoxia, neurodegeneration, and epilepsyAmalia Merelli, Liliana Czornyj, Alberto Lazarowski
Journal of Alzheimer'S Disease : JAD|December 16, 2020
Hypoxia, Oxidative Stress, and Inflammation: Three Faces of Neurodegenerative DiseasesAmalia Merelli, Marisa Repetto, Alberto Lazarowski, et al.
Neurotoxicity Research|April 23, 2009
Neuronal and glial alterations due to focal cortical hypoxia induced by direct cobalt chloride (CoCl2) brain injectionLaura Caltana, Amalia Merelli, Alberto Lazarowski, et al.
Molecular Pharmacology|March 4, 2008
P-glycoprotein--a clinical target in drug-refractory epilepsy?Robert W Robey, Alberto Lazarowski, Susan E Bates
Drug Metabolism and Drug Interactions|July 16, 2011
Experimental evidence of the potential use of erythropoietin by intranasal administration as a neuroprotective agent in cerebral hypoxiaAmalia Merelli, Laura Caltana, Alberto Lazarowski, et al.
International Journal of Laboratory Hematology|March 24, 2020
Paroxysmal nocturnal hemoglobinuria: Test to monitor the action of eculizumab treatmentMiriam Arcavi, Fernanda Ceballo, María Beatríz Caracciolo, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Frontiers in Bioscience (Landmark Edition)|June 5, 2014
ABC-transporters as stem-cell markers in brain dysplasia/tumor epilepsiesLilliana Czornyj, Alberto Lazarowski
Drug Metabolism and Drug Interactions|May 12, 2011
Potential role of multidrug resistant proteins in refractory epilepsy and antiepileptic drugs interactionsAlberto Lazarowski, Liliana Czornyj
Epilepsy & Behavior : E&B|November 11, 2019
The role of P-glycoprotein (P-gp) and inwardly rectifying potassium (Kir) channels in sudden unexpected death in epilepsy (SUDEP)Jerónimo Auzmendi, Enes Akyuz, Alberto Lazarowski
Epilepsia Open|September 20, 2021
Transporter hypothesis in pharmacoresistant epilepsies. Is it at the central or peripheral level?Liliana Czornyj, Jerónimo Auzmendi, Alberto Lazarowski
Current Pharmaceutical Design|March 28, 2013
Erythropoietin: a neuroprotective agent in cerebral hypoxia, neurodegeneration, and epilepsyAmalia Merelli, Liliana Czornyj, Alberto Lazarowski
Journal of Alzheimer'S Disease : JAD|December 16, 2020
Hypoxia, Oxidative Stress, and Inflammation: Three Faces of Neurodegenerative DiseasesAmalia Merelli, Marisa Repetto, Alberto Lazarowski, et al.
Neurotoxicity Research|April 23, 2009
Neuronal and glial alterations due to focal cortical hypoxia induced by direct cobalt chloride (CoCl2) brain injectionLaura Caltana, Amalia Merelli, Alberto Lazarowski, et al.
Molecular Pharmacology|March 4, 2008
P-glycoprotein--a clinical target in drug-refractory epilepsy?Robert W Robey, Alberto Lazarowski, Susan E Bates
Drug Metabolism and Drug Interactions|July 16, 2011
Experimental evidence of the potential use of erythropoietin by intranasal administration as a neuroprotective agent in cerebral hypoxiaAmalia Merelli, Laura Caltana, Alberto Lazarowski, et al.
International Journal of Laboratory Hematology|March 24, 2020
Paroxysmal nocturnal hemoglobinuria: Test to monitor the action of eculizumab treatmentMiriam Arcavi, Fernanda Ceballo, María Beatríz Caracciolo, et al.
Pageof 6